Get the content you want anytime you want.

Increase in Pneumococcal Vaccines Leads to Decrease in Ear Infections in Children

The rate of acute otitis media (AOM) in children in the United States has declined “threefold” in the past decade (when compared with infections in the 1980s) and the results of a recent study point to pneumococcal vaccines as the cause.

That’s the good news. The bad news is that the researchers also found that the types of bacteria that are causing the majority of ear infections today are not targeted by these vaccines. And, perhaps more alarming, these bacteria are not killed by amoxicillin, the first-line antibiotic recommended to treat the infections.

Michael Pichichero, MD, study author and director of the Rochester General Hospital Research Institute, Rochester, NY, remarked on these findings in the press release, stating, “The magnitude of the drop in the occurrence of ear infections was more than I expected. The second big finding is we've got this shift in the number 1 bacteria. If something is not done, I would expect ear infections to come back in frequency.”

The American Academy of Pediatrics reports that > 5 million ear infections occur in children in the United States each year. These infections result in > 10 million prescriptions for antibiotics and around 30 million medical care visits. The study authors note that Streptococcus pneumoniae is the most common cause of these infections.

For their study, Dr. Pichichero and his team looked at more than 600 children from 2006 to 2016. A total of “23% of the children experienced at least 1 ear infection, and 3.6% had at least 3 ear infections by 12 months of age. By the age of 3, about 60% of the children had 1 or more ear infections, and about 24% had 3 or more ear infections,” according to the press release.

These rates are still lower than was reported 30 years ago, and the researchers point to the introduction of the pneumococcal vaccine, which kills Streptococcus pneumoniae, as the cause. First introduced in 2000, and then “improved with a version that enhanced its effectiveness by protecting for additional strains of the bacteria,” in 2010, the pneumococcal vaccine is “routinely administered to babies in the United States as part of check-ups at 2, 4 and 6 months of age, with a booster given at 12 to 15 months,” according to Dr. Pichichero. (Only 1 dose is required for adults receiving the vaccine.)

Big advances in treatment can